Chapter PDF
Keywords
- Multiple Sclerosis
- Experimental Autoimmune Encephalomyelitis
- Progressive Multifocal Leukoencephalopathy
- Human Herpesvirus
- Immediate Early
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Ablashi, D. V., Eastman, H. B., Owen, C. B., et al. (2000) Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol. 16:179–191.
Ablashi, D. V., Lapps, W., Kaplan, M., et al. (1998) Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult. Scler. 4:490–496.
Akhyani, N., Berti, R., Brennan, M. B., et al. (2000) Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J. Infect. Dis. 182:1321–1325.
Al-Shammari, S., Nelson, R. F., Voevodin, A. (2003) HHV-6 DNAaemia in patients with multiple sclerosis in Kuwait. Acta Neurol. Scand. 107:122–124.
Albright, A. V., Lavi, E., Black, J. B., et al. (1998) The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J. Neurovirol. 4:486–494.
Alvarez-Lafuente, R., De Las Heras, V., Bartolome, M., et al. (2004a) Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission. Eur. Neurol. 52:87–91.
Alvarez-Lafuente, R., De las Heras, V., Bartolome, M., et al. (2004b) Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch. Neurol. 61:1523–1527.
Alvarez-Lafuente, R., Martin-Estefania, C., de las Heras, V., et al. (2002a) Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol. Scand. 105:95–99.
Alvarez-Lafuente, R., Martin-Estefania, C., de Las Heras, V., et al. (2002b) Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch. Neurol. 59:929–933.
Ascherio, A., Munger, K. L., Lennette, E. T., et al. (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. J.A.M.A. 286:3083–3088.
Babbe, H., Roers, A., Waisman, A., et al. (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:393–404.
Barry, M., Bleackley, R. C. (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2:401–409.
Barry, M., Heibein, J. A., Pinkoski, M. J., et al. (2000) Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol. Cell. Biol. 20:3781–3794.
Bech, E., Lycke, J., Gadeberg, P., et al. (2002) A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 58:31–36.
Berti, R., Brennan, M. B., Soldan, S. S., et al. (2002) Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J. Neurovirol. 8:250–256.
Berti, R., Soldan, S. S., Akhyani, N., et al. (2000) Extended observations on the association of HHV-6 and multiple sclerosis. J. Neurovirol. 6(Suppl 2):S85–S87.
Bethge, W., Beck, R., Jahn, G., et al. (1999) Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation. Bone Marrow Transplant 24:1245–1248.
Blumberg, B. M., Mock, D. J., Powers, J. M., et al. (2000) The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J. Clin. Virol. 16:159–178.
Booss, J., Esiri, M. M., Tourtellotte, W. W., Mason, D. Y. (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62:219–232.
Bray, P. F., Luka, J., Bray, P. F., et al. (1992) Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 42:1798–1804.
Brudek, T., Christensen, T., Hansen, H. J., et al. (2004) Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res. Hum. Retroviruses 20:415–423.
Campadelli-Fiume, G., Mirandola, P., Menotti, L. (1999) Human herpesvirus 6: an emerging pathogen. Emerg. Infect. Dis. 5:353–366.
Carbone, K. M., Luftig, D. B., Buckley, M. R. (2005) Microbial triggers of chronic human illness. In: American Academy of Microbiology Critical Issues Colloquia.
Caselli, E., Boni, M., Bracci, A., et al. (2002) Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis. J. Clin. Microbiol. 40:4131–4137.
Caserta, M. T., Hall, C. B., Schnabel, K., et al. (1994) Neuroinvasion and persistence of human herpesvirus 6 in children. J. Infect. Dis. 170:1586–1589.
Caserta, M. T., Mock, D. J., Dewhurst, S. (2001) Human herpesvirus 6. Clin. Infect. Dis. 33:829–833.
Cermelli, C., Berti, R., Soldan, S. S., et al. (2003) High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J. Infect. Dis. 187:1377–1387.
Cermelli, C., Jacobson, S. (2000) Viruses and multiple sclerosis. Viral Immunol. 13:255–267.
Challoner, P. B., Smith, K. T., Parker, J. D., et al. (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. U S A 92:7440–7444.
Chapenko, S., Millers, A., Nora, Z., et al. (2003) Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol. 69:111–117.
Christensen, T. (2005) Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol. 15:179–211.
Clark, D. (2004) Human herpesvirus type 6 and multiple sclerosis. Herpes 11(Suppl 2):112A–119A.
Coates, A. R., Bell, J. (1998) HHV-6 and multiple sclerosis. Nat. Med. 4:537–538.
Crawford, M. P., Yan, S. X., Ortega, S. B., et al. (2004) High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103:4222–4231.
De Bolle, L., Naesens, L., De Clercq, E. (2005) Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 18:217–245.
Denes, E., Magy, L., Pradeau, K., et al. (2004) Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient. Emerg. Infect. Dis. 10:729–731.
Derfuss, T., Hohlfeld, R., Meinl, E. (2005) Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J. Neurol. 252:968–971.
Dewhurst, S., McIntyre, K., Schnabel, K., Hall, C. B. (1993) Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J. Clin. Microbiol. 31:416–418.
Dolei, A., Serra, C., Mameli, G., et al. (2002) Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 58:471–473.
Dyment, D. A., Ebers, G. C., Sadovnick, A. D. (2004) Genetics of multiple sclerosis. Lancet Neurol 3:104–110.
Ebers, G. C., Sadovnick, A. D., Risch, N. J. (1995) A genetic basis for familial aggregation in multiple sclerosis: Canadian Collaborative Study Group. Nature 377:150–151.
Enbom, M., Wang, F. Z., Fredrikson, S., et al. (1999) Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin. Diagn. Lab. Immunol. 6:545–549.
Ermann, J., Fathman, C. G. (2001) Autoimmune diseases: genes, bugs and failed regulation. Nat. Immunol. 2:759–761.
Ffrench-Constant, C. (1994) Pathogenesis of multiple sclerosis. Lancet 343:271–275.
Fillet, A. M., Lozeron, P., Agut, H., et al. (1998) HHV-6 and multiple sclerosis. Nat. Med. 4:537, author reply 538.
Friedman, J. E., Lyons, M. J., Cu, G., et al. (1999) The association of the human herpesvirus-6 and MS. Mult. Scler. 5:355–362.
Friedman, J. E., Zabriskie, J. B., Plank, C., et al. (2005) A randomized clinical trial of valacyclovir in multiple sclerosis. Mult. Scler. 11:286–295.
Fujinami, R. S., von Herrath, M. G., Christen, U., Whitton, J. L. (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin. Microbiol. Rev. 19:80–94.
Gilden, D. H. (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4:195–202.
Gilden, D. H., Devlin, M. E., Burgoon, M. P., Owens, G. P. (1996).The search for virus in multiple sclerosis brain. Mult. Scler. 2:179–183.
Goldberg, S. H., Albright, A. V., Lisak, R. P., Gonzalez-Scarano, F. (1999) Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. J. Neurovirol. 5:134–139.
Goodman, A. D., Mock, D. J., Powers, J. M., et al. (2003) Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J. Infect. Dis. 187:1365–1376.
Goverman, J., Woods, A., Larson, L., et al. (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551–560.
Green, D. R., Droin, N., Pinkoski, M. (2003) Activation-induced cell death in T cells. Immunol. Rev. 193:70–81.
Guggenmos, J., Schubart, A. S., Ogg, S., et al. (2004) Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J. Immunol. 172:661–668.
Haahr, S., Sommerlund, M., Moller-Larsen, A., et al. (1991) Just another dubious virus in cells from a patient with multiple sclerosis? Lancet 337:863–864.
Haines, J. L., Terwedow, H. A., Burgess, K., et al. (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity: the Multiple Sclerosis Genetics Group. Hum Mol Genet 7:1229–1234.
Hall, C. B., Caserta, M. T., Schnabel, K. C., et al. (1998) Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin. Infect. Dis. 26:132–137.
Hall, C. B., Long, C. E., Schnabel, K. C, et al. (1994) Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N. Engl. J. Med. 331:432–438.
He, J., McCarthy, M., Zhou, Y., et al. (1996) Infection of primary human fetal astrocytes by human herpesvirus 6. J. Virol. 70:1296–1300.
Hemmer, B., Archelos, J. J., Hartung, H. P. (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3:291–301.
Hilton, D. A., Love, S., Fletcher, A., Pringle, J. H. (1994) Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation. J. Neurol. Neurosurg. Psychiatry 57:975–976.
Hong, J., Tejada-Simon, M. V., Rivera, V. M., et al. (2002) Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult. Scler. 8:237–242.
Huseby, E. S., Liggitt, D., Brabb, T., et al. (2001) A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194:669–676.
IFNB (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial; the IFNB Multiple Sclerosis Study Group. Neurology 43:655–661.
Johnson, R. T. (1994) The virology of demyelinating diseases. Ann. Neurol. 36(Suppl):S54–S60.
Johnston, R. E., Geretti, A. M., Prentice, H. G., et al. (1999) HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br. J. Haematol. 105:1041–1043.
Kimberlin, D. W. (1998) Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease. Pediatr. Infect. Dis. J. 17:59–67; quiz 68.
Knox, K. K., Brewer, J. H., Henry, J. M., et al. (2000) Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin. Infect. Dis. 31:894–903.
Kurtzke, J. F. (2000) Epidemiology of multiple sclerosis: does this really point toward an etiology? Lectio doctoralis. Neurol. Sci. 21:383–403.
Lawrence, G. L., Chee, M., Craxton, M. A., et al. (1990) Human herpesvirus 6 is closely related to human cytomegalovirus. J. Virol. 64:287–299.
Levin, L. I., Munger, K. L., Rubertone, M. V., et al. (2005) Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. J.A.M.A. 293:2496–2500.
Liedtke, W., Malessa, R., Faustmann, P. M., Eis-Hubinger, A. M. (1995) Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J. Neurovirol. 1:253–258.
Lindberg, C., Andersen, O., Vahlne, A., et al. (1991) Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 10:62–65.
Lusso, P., Markham, P. D., Tschachler, E., et al. (1988) In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J. Exp. Med. 167:1659–1670.
Marie, P. (1884) Sclerose en plaques et maladies infectieuses. Prog. Med. Paris 12:287–289.
Martin, C., Enbom, M., Soderstrom, M., et al. (1997) Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol. Scand. 95:280–283.
McCullers, J. A., Lakeman, F. D., Whitley, R. J. (1995) Human herpesvirus 6 is associated with focal encephalitis. Clin. Infect. Dis. 21:571–576.
McFarland, H. F., Reingold, S. C. (2005) The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era. Mult. Scler. 11:669–676.
Medana, I. M., Gallimore, A., Oxenius, A., et al. (2000) MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur. J. Immunol. 30:3623–3633.
Mirandola, P., Menegazzi, P., Merighi, S., et al. (1998) Temporal mapping of transcripts in herpesvirus 6 variants. J. Virol. 72:3837–844.
Mirandola, P., Stefan, A., Brambilla, E., et al. (1999) Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 53:1367–1368.
Mock, D. J., Powers, J. M., Goodman, A. D., et al. (1999) Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy. J. Neurovirol. 5:363–373.
Monteiro, J., Hingorani, R, Pergolizzi, R., et al. (1995) Clonal dominance of CD8+ T-cell in multiple sclerosis. Ann. N.Y. Acad. Sci. 756:310–312.
Mookerjee, B. P., Vogelsang, G. (1997) Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant. 20:905–906.
Morre, S. A., van Beek, J., De Groot, C. J., et al. (2001) Is Epstein-Barr virus present in the CNS of patients with MS? Neurology 56:692.
Mouzaki, A., Tselios, T., Papathanassopoulos, P., et al. (2004) Immunotherapy for multiple sclerosis: basic insights for new clinical strategies. Curr. Neurovasc. Res. 1:325–340.
Neumann, H., Medana, I. M., Bauer, J., Lassmann, H. (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25:313–319.
Nielsen, L., Larsen, A. M., Munk, M., Vestergaard, B. F. (1997) Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis. Acta Neurol. Scand. Suppl. 169:76–78.
Okuno, T., Takahashi, K., Balachandra, K., et al. (1989) Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J. Clin. Microbiol. 27:651–653.
Ongradi, J., Rajda, C., Marodi, CL., et al. (1999) A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J. Neurovirol. 5:529–532.
Opsahl, M. L., Kennedy, P. G. (2005) Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 128:516–527.
Rapaport, D., Engelhard, D., Tagger, G., et al. (2002) Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl. Infect. Dis. 4:10–16.
Rieux, C., Gautheret-Dejean, A., Challine-Lehmann, D., et al. (1998) Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation. Transplantation 65:1408–1411.
Rossi, C., Delforge, M. L., Jacobs, F., et al. (2001) Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation 71:288–292.
Rotola, A., Merlotti, I., Caniatti, L., et al. (2004) Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult. Scler. 10:348–354.
Russell, J. H., Ley, T. J. (2002) Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20:323–370.
Saito, Y., Sharer, L. R., Dewhurst, S., et al. (1995) Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J. Neurovirol. 1:30–39.
Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., et al. (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596–601.
Sanders, V. J., Felisan, S., Waddell, A., Tourtellotte, W. W. (1996) Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J. Neurovirol. 2:249–258.
Shresta, S., Pham, C. T., Thomas, D. A., et al. (1998) How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10:581–587.
Sibley, W. A., Bamford, C. R., Clark, K. (1985) Clinical viral infections and multiple sclerosis. Lancet 1:1313–1315.
Singh, N., Bonham, A., Fukui, M. (2000) Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 69:467–472.
Sola, P., Merelli, E., Marasca, R., et al. (1993) Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J. Neurol. Neurosurg. Psychiatry 56:917–919.
Soldan, S. S., Berti, R., Salem, N., et al. (1997) Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3:1394–1397.
Soldan, S. S., Leist, T. P., Juhng, K. N., et al. (2000) Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann. Neurol. 47:306–313.
Sospedra, M., Martin, R. (2005) Immunology of multiple sclerosis. Annu. Rev. Immunol. 23:683–747.
Steinman, L. (2001a) Multiple sclerosis: a two-stage disease. Nat. Immunol. 2:762–764.
Steinman, L. (2001b). Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194:F27–F30.
Steinman, L., Zamvil, S. (2003) Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol. 3:483–492.
Sundstrom, P., Juto, P., Wadell, G., et al. (2004) An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 62:2277–2282.
Swanborg, R. H., Whittum-Hudson, J. A., Hudson, A. P. (2003) Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved? J. Neuroimmunol. 136:1–8.
Taus, C., Pucci, E., Cartechini, E., et al. (2000) Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol. Scand. 101:224–228.
Tejada-Simon, M. V., Zang, Y. C., Hong, J., et al. (2002) Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J. Virol. 76:6147–6154.
Tiacci, E., Luppi, M., Barozzi, P., et al. (2000) Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor. Haematologica 85:94–97.
Tokimasa, S., Hara, J., Osugi, Y., et al. (2002) Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 29:595–598.
Tomsone, V., Logina, I., Millers, A., et al. (2001) Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system. J. Neurovirol. 7:564–569.
Trapani, J. A., Davis, J., Sutton, V. R., Smyth, M. J. (2000) Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr. Opin. Immunol. 12:323–329.
Vass, K., Lassmann, H. (1990) Intrathecal application of interferon gamma: progressive appearance of MHC antigens within the rat nervous system. Am. J. Pathol. 137:789–800.
Villoslada, P., Juste, C., Tintore, M., et al. (2003) The immune response against herpesvirus is more prominent in the early stages of MS. Neurology 60:1944–1948.
Virtanen, J. O., Zabriskie, J. B., Siren, V., et al. (2005) Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue. Med. Sci. Monit. 11:BR84-BR87.
Wainwright, M. S., Martin, P. L., Morse, R. P., et al. (2001) Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann. Neurol. 50:612–619.
Wang, F. Z., Linde, A., Hagglund, H., et al. (1999) Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin. Infect. Dis. 28:562–568.
Wilborn, F., Schmidt, C. A., Brinkmann, V., et al. (1994) A potential role for human herpesvirus type 6 in nervous system disease. J. Neuroimmunol. 49:213–214.
Woodland, D. L., Dutton, R. W. (2003) Heterogeneity of CD4(+) and CD8(+) T cells. Curr. Opin. Immunol. 15:336–342.
Wucherpfennig, K. W., Strominger, J. L. (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695–705.
Xu, Y., Linde, A., Fredrikson, S., et al. (2002) HHV-6 A- or B-specific P41 antigens do not reveal virus variant-specific IgG or IgM responses in human serum. J. Med. Virol. 66:394–399.
Yamanishi, K., Okuno, T., Shiraki, K., et al. (1988) Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1:1065–1067.
Yoshida, H., Matsunaga, K., Ueda, T., et al. (2002) Human herpesvirus 6 meningoencephalitis successfully treated with ganciclovir in a patient who underwent allogeneic bone marrow transplantation from an HLA-identical sibling. Int. J. Hematol. 75:421–425.
Yoshikawa, T., Asano, Y. (2000) Central nervous system complications in human herpesvirus-6 infection. Brain Dev. 22:307–314.
Zawada, M., Liwien, I., Pernak, M., et al. (2003) MSRV pol sequence copy number as a potential marker of multiple sclerosis. Pol. J. Pharmacol. 55:869–875.
Zerr, D. M., Gupta, D., Huang, M. L., et al. (2002) Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:309–317.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Williams, E.L., Jacobson, S. (2007). Viral Infection and Multiple Sclerosis. In: Zhang, J. (eds) Immune Regulation and Immunotherapy in Autoimmune Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36003-4_11
Download citation
DOI: https://doi.org/10.1007/978-0-387-36003-4_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-36002-7
Online ISBN: 978-0-387-36003-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)